E-Mon, LLC Announces Reseller Agreement With Tridium, Inc.

Business Wire | October 26, 2007 | Copyright

E-Mon to Incorporate Tridium's Niagara(AX[R]) and JACE([R])-2 Technologies to Extend Internet and Modbus Compatible Submetering into Nationwide Building Automation and Systems Integrator Markets

LANGHORNE, Pa. -- E-Mon, the electric submetering market leader and manufacturer of the widely installed E-Mon D-Mon[R] product line, today announced a reseller agreement with Richmond, VA-based Tridium, Inc., the leading global provider of device-to-enterprise application software and Internet-based solutions. Under the terms of the agreement, E-Mon will focus on the ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Shire to Introduce a New UK Listed Holding Company.
PR Newswire Europe ; ...PROSPECTUS EXPECTED TO BE PUBLISHED BY SHIRE LIMITED IN CONNECTION WITH THE PROPOSED...WILL BE PUBLISHED AND MADE AVAILABLE ON SHIRE'S WEBSITE AND WILL BE AVAILABLE FOR INSPECTION...AUTHORITY'S DOCUMENT VIEWING FACILITY Shire plc ("Shire") (LSE: SHP, NASDAQ...
SHIRE PLC - SHIRE TO INTRODUCE A NEW UK LISTED HOLDING COMPANY.
PR Newswire UK Disclose ; ...PROSPECTUS EXPECTED TO BE PUBLISHED BY SHIRE LIMITED IN CONNECTION WITH THE PROPOSED...WILL BE PUBLISHED AND MADE AVAILABLE ON SHIRE'S WEBSITE AND WILL BE AVAILABLE FOR INSPECTION...AUTHORITY'S DOCUMENT VIEWING FACILITY SHIRE TO INTRODUCE A NEW UK LISTED HOLDING COMPANY...
SHIRE PLC - Application for Listing of Shire Limited Ordinary Shares.
PR Newswire UK Disclose ; Application for Listing of Shire Limited Ordinary Shares Basingstoke, UK and Philadelphia, US - May 23, 2008 - Shire Limited ("Shire") (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical...
Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans.
News Wire article from: PR Newswire ; Free Medication Provided by Shire to Patients Taking Lialda(R) (mesalamine...May 18 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical...gastrointestinal (GI) medications from Shire by expanding its Patient Assistant Program...
SHIRE PLC - Purchase of Shares by Employee Benefit Trust.
PR Newswire UK Disclose ; 8 March 2007 Shire plc ("Shire") Purchase of Shares by Employee Benefit Trust Shire has been notified that on 7 March 2007, the Shire plc Employee Benefit Trust (the "Trust") purchased 50,000 Ordinary Shares of Shire plc ("Shares...
Shire Launches Clinical Study Results Website.
PR Newswire ; ...Enhances the Availability of Information for Shire Marketed Medicines BASINGSTOKE, England...reporting of clinical trial study results, Shire plc, the global specialty biopharmaceutical...website that offers access to specific Shire-sponsored clinical trials. The new site...
Shire Pharmaceuticals Group PLC - Court Sets New Trial Date For Impax Cases - Feb 2006.
Newspaper article from: PR Newswire UK Disclose ; ...and Philadelphia, US - April 15, 2005 - Shire Pharmaceuticals Group plc (LSE: SHP...Deficit Hyperactivity Disorder (ADHD). Shire has previously announced two pending suits...cases. Also, as previously announced, Shire has received Paragraph IV notice letters...
Shire Announces Posting of Circular, Date of Extraordinary General Meeting and Extension of Tender Offer for New River Shares Until April 17, 2007.
PR Newswire ; ...March 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP.L; NASDAQ: SHPGY; TSX: SHQ) ("Shire" or the "Company") today announced the...Southampton Buildings, London, WC2A 1PB. Shire also announced today that its wholly owned...
Shire Pharmaceuticals Group PLC - PRODUCT DEVELOPMENT UPDATE SESSION - May 10th.
Newspaper article from: PR Newswire UK Disclose ; ...and Philadelphia, US - April 15, 2005 - Shire Pharmaceuticals Group plc (LSE: SHP...The presentation will focus on three key Shire development candidates: MTS (ADHD...RSVP via: Souheil Salah ssalah@uk.shire.com (T: +44 (0)1256 894 160) Heidi...
Shire to Build on Specialty Portfolio Through Acquisition of Transkaryotic Therapies, Inc. for $1.6 Billion.
PR Newswire ; ...April 21 /PRNewswire-FirstCall/ -- Shire Pharmaceuticals Group plc (LSE: SHP.L; NASDAQ:SHPGY; TSX:SHQ) ("Shire") announced today that it has signed...billion. The acquisition is consistent with Shire's strategy and highly complementary to...

Find more facts and information related to the article "E-Mon, LLC Announces Reseller Agreement With ..."